165 related articles for article (PubMed ID: 7906978)
1. [Amplification and expression of HER-2 oncogene in precancerous stages and cancers of the endometrium].
Czerwenka KF; Heuss F; Zeillinger R; Hosmann JW; Wagner T; Manavi M; Jelincic D; Lu Y; Kubista E
Gynakol Geburtshilfliche Rundsch; 1993; 33 Suppl 1():287-8. PubMed ID: 7906978
[No Abstract] [Full Text] [Related]
2. Molecular profiles of benign and (pre)malignant endometrial lesions.
van der Putten LJM; van Hoof R; Tops BBJ; Snijders MPLM; van den Berg-van Erp SH; van der Wurff AAM; Bulten J; Pijnenborg JMA; Massuger LFAG
Carcinogenesis; 2017 Mar; 38(3):329-335. PubMed ID: 28203752
[TBL] [Abstract][Full Text] [Related]
3. [Precursor lesions of endometrial carcinoma: diagnostic approach and molecular pathology].
Lax S
Pathologe; 2011 Nov; 32 Suppl 2():255-64. PubMed ID: 22033684
[TBL] [Abstract][Full Text] [Related]
4. Oncogenic potential of c-erbB-2 and its association with c-K-ras in premalignant and malignant lesions of the human uterine endometrium.
Manavi M; Bauer M; Baghestanian M; Berger A; Kucera E; Pischinger K; Battistutti W; Czerwenka K
Tumour Biol; 2001; 22(5):299-309. PubMed ID: 11553860
[TBL] [Abstract][Full Text] [Related]
5. Laminin C1 expression by uterine carcinoma cells is associated with tumor progression.
Kashima H; Wu RC; Wang Y; Sinno AK; Miyamoto T; Shiozawa T; Wang TL; Fader AN; Shih IeM
Gynecol Oncol; 2015 Nov; 139(2):338-44. PubMed ID: 26343160
[TBL] [Abstract][Full Text] [Related]
6. [Pitfalls in the histopathological diagnostics of endometrial carcinoma and its precursors : Clinically relevant differential diagnoses, avoidance of false positive diagnoses].
Kommoss F; Lax SF
Pathologe; 2016 Nov; 37(6):512-520. PubMed ID: 27681950
[TBL] [Abstract][Full Text] [Related]
7. ERBB2 (HER2/neu) oncogene is frequently amplified in squamous cell carcinoma of the uterine cervix.
Mitra AB; Murty VV; Pratap M; Sodhani P; Chaganti RS
Cancer Res; 1994 Feb; 54(3):637-9. PubMed ID: 7905784
[TBL] [Abstract][Full Text] [Related]
8. PINCH protein expression in normal endometrium, atypical endometrial hyperplasia and endometrioid endometrial carcinoma.
Zhang HZ; Li XH; Zhang X; Zhang ZY; Meng YL; Xu SW; Zheng Y; Zhu ZL; Cui DS; Huang LX; Yan BY; Sun XF
Chemotherapy; 2010; 56(4):291-7. PubMed ID: 20714146
[TBL] [Abstract][Full Text] [Related]
9. Distinct telomere length regulation in premalignant cervical and endometrial lesions: implications for the roles of telomeres in uterine carcinogenesis.
Maida Y; Kyo S; Forsyth NR; Takakura M; Sakaguchi J; Mizumoto Y; Hashimoto M; Nakamura M; Nakao S; Inoue M
J Pathol; 2006 Oct; 210(2):214-23. PubMed ID: 16909412
[TBL] [Abstract][Full Text] [Related]
10. Assessment of HER-2/neu, с-MYC and CCNE1 gene copy number variations and protein expression in endometrial carcinomas.
Buchynska LG; Brieieva OV; Iurchenko NP
Exp Oncol; 2019 Jun; 41(2):138-143. PubMed ID: 31262163
[TBL] [Abstract][Full Text] [Related]
11. Benign and Premalignant Lesions of the Endometrium.
Mallinger WD; Quick CM
Surg Pathol Clin; 2019 Jun; 12(2):315-328. PubMed ID: 31097106
[TBL] [Abstract][Full Text] [Related]
12. A proposed model for endometrial serous carcinogenesis.
Zheng W; Xiang L; Fadare O; Kong B
Am J Surg Pathol; 2011 Jan; 35(1):e1-e14. PubMed ID: 21164282
[TBL] [Abstract][Full Text] [Related]
13. Prospective analysis of DNA ploidy, proliferative index and epidermal growth factor receptor as prognostic factors for pretreated uterine cancer.
Nagai N; Oshita T; Fujii T; Kioka H; Katsube Y; Ohama K
Oncol Rep; 2000; 7(3):551-9. PubMed ID: 10767367
[TBL] [Abstract][Full Text] [Related]
14. DNA ploidy and S-phase fraction analyses of hyperplastic, atypical and cancerous endometrium using flow cytometry from paraffin-embedded tissues.
Pervez S; Hitchcock A; Sinton TM; Mani A; Smith JL
Pathol Res Pract; 2002; 198(1):13-7. PubMed ID: 11866205
[TBL] [Abstract][Full Text] [Related]
15. [Molecular and clinical endocrinology of the endometrium].
Bamberger AM; Kleinkauf-Houcken A; Bamberger CM; Löning T
Pathologe; 1999 Jan; 20(1):50-5. PubMed ID: 10091232
[TBL] [Abstract][Full Text] [Related]
16. [Dualistic model of molecular pathogenesis in endometrial carcinoma].
Lax SF
Zentralbl Gynakol; 2002 Jan; 124(1):10-6. PubMed ID: 11873308
[TBL] [Abstract][Full Text] [Related]
17. Endometrial tumorigenesis in Pten(+/-) mice is independent of coexistence of estrogen and estrogen receptor α.
Joshi A; Wang H; Jiang G; Douglas W; Chan JS; Korach KS; Ellenson LH
Am J Pathol; 2012 Jun; 180(6):2536-47. PubMed ID: 22503752
[TBL] [Abstract][Full Text] [Related]
18. Oestrogen receptor gene (ESR1) amplification is frequent in endometrial carcinoma and its precursor lesions.
Lebeau A; Grob T; Holst F; Seyedi-Fazlollahi N; Moch H; Terracciano L; Turzynski A; Choschzick M; Sauter G; Simon R
J Pathol; 2008 Oct; 216(2):151-7. PubMed ID: 18720455
[TBL] [Abstract][Full Text] [Related]
19. Sporadic microsatellite instability is specific to neoplastic and preneoplastic endometrial tissues.
Faquin WC; Fitzgerald JT; Lin MC; Boynton KA; Muto MG; Mutter GL
Am J Clin Pathol; 2000 Apr; 113(4):576-82. PubMed ID: 10787358
[TBL] [Abstract][Full Text] [Related]
20. [Demonstration and biological significance of viral and cellular oncogenes in uterine carcinomas].
Milde-Langosch K; Wilckens C; Brack T; Löning T
Verh Dtsch Ges Pathol; 1991; 75():363-5. PubMed ID: 1724842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
